cephalosporin c has been researched along with cefteram in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (75.00) | 18.7374 |
1990's | 3 (15.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiraoka, M; Inoue, M; Matsui, H; Mitsuhashi, S | 1 |
Black, WA; Bowie, WR; Chan, DG; Shaw, CE | 1 |
Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA | 1 |
Jalanko, E; Renkonen, OV; Scheinin, L; Valle, T | 1 |
Easmon, CS; Ison, CA; Woodford, N | 1 |
Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
Hohl, P; Kafader, FM; Salfinger, M | 1 |
Aldridge, KE; Sanders, CV; Schiro, DD | 1 |
Chang, D; Garland, W; Oldfield, N; Town, C | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Arnold, K; Chau, PY; Leung, YK; Ng, WW | 1 |
Barry, AL; Jones, RN | 1 |
Houben, AW; Stobberingh, E; van Boven, CP | 1 |
Andrews, JM; Piddock, LJ; Wise, R | 1 |
Fass, RJ; Helsel, VL | 1 |
Li, G; Wu, J; Zhang, Y | 1 |
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Furuki, A; Hasegawa, M; Kanayama, A; Kobayashi, I; Matsuzaki, K; Sato, Y; Watabe, E | 1 |
1 trial(s) available for cephalosporin c and cefteram
Article | Year |
---|---|
[A randomized control study on the treatment of 123 cases of bacterial infections with cefteram and cefaclor].
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cefmenoxime; Cephalosporins; Cystitis; Humans; Tonsillitis | 1995 |
19 other study(ies) available for cephalosporin c and cefteram
Article | Year |
---|---|
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1990 |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Chlamydia trachomatis; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1987 |
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 1987 |
In vitro activity of RO 15-8074 and RO 19-5247.
Topics: Amoxicillin; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus; Streptococcus | 1987 |
The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Neisseria gonorrhoeae; Penicillin Resistance | 1987 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
Topics: Cefmenoxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1987 |
Quantitation of ceftetrame in human plasma and urine by high-performance liquid chromatography.
Topics: Adult; Cefmenoxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Male; Reference Standards; Spectrophotometry, Ultraviolet | 1987 |
In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Ceftizoxime; Cephalosporins; Enzyme Stability; Microbial Sensitivity Tests | 1986 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1987 |
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Computers; Microbial Sensitivity Tests; Predictive Value of Tests; Regression Analysis | 1987 |
In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247.
Topics: Aztreonam; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Enterobacteriaceae; Pseudomonas | 1987 |
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
Topics: Bacteria; Blood Proteins; Cefmenoxime; Ceftizoxime; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Protein Binding | 1986 |
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1986 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
[Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefmenoxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Japan; Streptococcus pneumoniae; Time Factors | 2004 |